179 related articles for article (PubMed ID: 1282961)
21. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.
Stamler JS; Loh E; Roddy MA; Currie KE; Creager MA
Circulation; 1994 May; 89(5):2035-40. PubMed ID: 7514109
[TBL] [Abstract][Full Text] [Related]
22. Nitric oxide-endothelin-1 interaction in humans.
Ahlborg G; Lundberg JM
J Appl Physiol (1985); 1997 May; 82(5):1593-600. PubMed ID: 9134909
[TBL] [Abstract][Full Text] [Related]
23. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats.
Barer G; Emery C; Stewart A; Bee D; Howard P
J Physiol; 1993 Apr; 463():1-16. PubMed ID: 8246176
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition.
Pizcueta P; Piqué JM; Fernández M; Bosch J; Rodés J; Whittle BJ; Moncada S
Gastroenterology; 1992 Dec; 103(6):1909-15. PubMed ID: 1451984
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of nitric oxide synthase in human skin.
Goldsmith PC; Leslie TA; Hayes NA; Levell NJ; Dowd PM; Foreman JC
J Invest Dermatol; 1996 Jan; 106(1):113-8. PubMed ID: 8592060
[TBL] [Abstract][Full Text] [Related]
26. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors.
Mitchell JA; Kohlhaas KL; Sorrentino R; Warner TD; Murad F; Vane JR
Br J Pharmacol; 1993 May; 109(1):265-70. PubMed ID: 7684306
[TBL] [Abstract][Full Text] [Related]
27. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
Artery; 1998; 23(1):1-9. PubMed ID: 10846613
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans.
Haynes WG; Noon JP; Walker BR; Webb DJ
J Hypertens; 1993 Dec; 11(12):1375-80. PubMed ID: 7510736
[TBL] [Abstract][Full Text] [Related]
29. Role of superoxide dismutase and nitric oxide on the interaction between brain and systemic circulation during brain ischemia.
Sakashita N; Ando Y; Yonehara T; Tanaka Y; Sato K; Uchino M; Ando M
Biochim Biophys Acta; 1994 Oct; 1227(1-2):67-73. PubMed ID: 7522576
[TBL] [Abstract][Full Text] [Related]
30. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
[TBL] [Abstract][Full Text] [Related]
31. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
33. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension.
Calver A; Collier J; Vallance P
Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide synthase inhibition with NG-mono-methyl-L-arginine reversibly decreases cerebral blood flow in piglets.
Greenberg RS; Helfaer MA; Kirsch JR; Moore LE; Traystman RJ
Crit Care Med; 1994 Mar; 22(3):384-92. PubMed ID: 7510221
[TBL] [Abstract][Full Text] [Related]
35. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
Cannan CR; Burnett JC; Brandt RR; Lerman A
Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat.
Tanaka K; Fukuuchi Y; Gomi S; Mihara B; Shirai T; Nogawa S; Nozaki H; Nagata E
Neuroreport; 1993 Mar; 4(3):267-70. PubMed ID: 8477049
[TBL] [Abstract][Full Text] [Related]
37. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers.
Kiowski W; Linder L; Stoschitzky K; Pfisterer M; Burckhardt D; Burkart F; Bühler FR
Circulation; 1994 Jul; 90(1):27-34. PubMed ID: 8026008
[TBL] [Abstract][Full Text] [Related]
38. Protective and pathological roles of nitric oxide in endotoxin shock.
Wright CE; Rees DD; Moncada S
Cardiovasc Res; 1992 Jan; 26(1):48-57. PubMed ID: 1516112
[TBL] [Abstract][Full Text] [Related]
39. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.
Corbett JA; Tilton RG; Chang K; Hasan KS; Ido Y; Wang JL; Sweetland MA; Lancaster JR; Williamson JR; McDaniel ML
Diabetes; 1992 Apr; 41(4):552-6. PubMed ID: 1376704
[TBL] [Abstract][Full Text] [Related]
40. Role of basal and stimulated release of nitric oxide in the regulation of radial artery caliber in humans.
Joannides R; Richard V; Haefeli WE; Linder L; Lüscher TF; Thuillez C
Hypertension; 1995 Aug; 26(2):327-31. PubMed ID: 7635543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
